MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2325/jbcs.13.289

Медицинская библиотека · Breast cancer (Tokyo, Japan) · 2006

A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy.

Nose Takayuki, Komoike Yoshihumi, Yoshida Ken, Koizumi Masahiko, Motomura Kazuyoshi, Kasugai Tsutomu, Inaji Hideo, Nishiyama Kinji, Koyama Hiroki, Kozuka Takuyo, Gomi Kotaro, Oguchi Masahiko, Akahashi Yutaka, Sumida Iori, Yamashita Takashi

Клиническое исследование I фазыКлиническое исследование II фазыСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Accelerated partial breast irradiation (APBI) is generally limited to patients at extremely low risk of local recurrence. The significance of the risk factors, however, depends on the extent of surgery, radiation, and systemic therapy. In Japan, wide excision is generally supplemented by intraoperative margin-directed re-excision if the frozen section examination yields positive results. This approach combined with conventional radiotherapy achieved an excellent 10-year local control rate of 93%, and young age and ductal carcinoma in situ were not risk factors for local recurrence. To reduce the treatment duration, high-dose-rate interstitial brachytherapy (HDRIB) was employed. The first APBI phase I / II trial in Japan was conducted to determine if wider indications for early breast cancer patients were appropriate.

METHODS

The subjects comprised 20 patients including those with extensive intraductal component (n=7), ductal carcinoma in situ (n=2), positive final margins (n=3), and of younger age (< or = 45 years; n=5). Breast-conserving surgery using an intraoperative re-excision approach was followed by intraoperative implantation of applicators. Sole HDRIB of a 36-42 Gy in 6-7 fractions was delivered postoperatively over 3-4 days. Tumors were staged as follows: cT1 (n=12), cT2 (n=8), cN0 (n=20). Systemic therapy was used in 16 patients (80%). The median follow-up period was 52 months (range, 26-86 months).

RESULTS

Te five-year crude local, distant control, and Kaplan-Meier cause-specific survival rates were 95%, 95%, and 89%, respectively. Fat necrosis developed in 1 patient.

CONCLUSIONS

Sole HDRIB with intraoperative margin-directed re-excision was feasible under wider indications compared to other contemporary APBI series, and achieved acceptable and similar results to these series in terms of the local control rate and complications.

Для цитирования: Nose Takayuki, Komoike Yoshihumi, Yoshida Ken, Koizumi Masahiko, Motomura Kazuyoshi, Kasugai Tsutomu, Inaji Hideo, Nishiyama Kinji, Koyama Hiroki, Kozuka Takuyo, Gomi Kotaro, Oguchi Masahiko, Akahashi Yutaka, Sumida Iori, Yamashita Takashi. A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy.. Breast cancer (Tokyo, Japan). 2006. DOI: 10.2325/jbcs.13.289.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.